...
首页> 外文期刊>PDA journal of pharmaceutical science and technology >Frequency analyses can be improved by a modified t-test in sample-based preclinical efficacy studies
【24h】

Frequency analyses can be improved by a modified t-test in sample-based preclinical efficacy studies

机译:可以通过基于样本的临床前功效研究中的改良t检验来改善频率分析

获取原文
获取原文并翻译 | 示例
           

摘要

Sample-based preclinical drug efficacy studies compare frequency (proportion) or incidences of successes within respective samples of test and control groups. The word success in principle refers to a protected (e.g., due to vaccination), recovered, or surviving animal, depending on the particular experiment. We introduce here a modified t-test for two independent groups, aimed at statistical analysis of the difference between frequencies of successes in sample based preclinical studies. The test is applicable whenever the study is based on repeating replicate experiments, as required by certain procedures such as validation. Such experiments are based on constant drug dose and performed under identical conditions and protocol. The proposed test combines the computational rules of t-test for two independent groups and analysis of variance. In the initial steps, incidences are transformed to proportions, and variance between proportions in samples of the jth group (S?pj 2 ), is then transformed into theoretical weighted variance within the ith repetition (sample) of the j th group (S?i, j 2 ). The variance of proportions in samples of the size of the whole group (SEj 2) is then calculated. The t-statistic is computed according to the rules of t-test for two independent groups. Significance is calculated using (N1 - 1) + (N2 - 1) degrees of freedom, where N j denotes the total number of animals in the jth group. The proposed model offers an important advantage over incidence or proportion distribution models, such as chi-square or normal approximation of binomial distribution, respectively, because it considers variance between replicate experiments. It moreover offers important flexibility by limiting the requirement for identical sample sizes only to samples within the control or test group. A difference between groups in sample sizes, number of samples, or both, preventing application of block designs or the standard formats of t-test, may still exist. Theoretical considerations and working examples are provided.
机译:基于样本的临床前药物功效研究比较了测试组和对照组各自样本中的频率(比例)或成功发生率。成功一词原则上是指受保护的动物(例如由于接种疫苗),已恢复或存活的动物,具体取决于特定的实验。我们在这里介绍针对两个独立组的改进的t检验,旨在对基于样本的临床前研究中成功频率之间的差异进行统计分析。只要研究是基于重复的重复实验(如某些程序(例如验证)所要求的),则该测试适用。此类实验基于恒定的药物剂量,并且在相同的条件和方案下进行。拟议的测试结合了两个独立组的t检验的计算规则和方差分析。在最初的步骤中,将发生率转换为比例,然后将第j组样本(S?pj 2)中各比例之间的方差转化为第j组(S?pj)的第i个重复(样本)内的理论加权方差。 i,j 2)。然后计算整个组大小(SEj 2)的样本中比例的方差。根据两个独立组的t检验规则计算t统计量。使用(N1-1)+(N2-1)自由度计算显着性,其中N j表示第j组中的动物总数。所提出的模型相对于发病率或比例分布模型(例如,二项分布的卡方或正态近似)具有重要优势,因为它考虑了重复实验之间的差异。此外,它通过将对相同样本大小的要求仅限制为对照组或测试组内的样本,提供了重要的灵活性。样本大小,样本数量或两者之间的组之间的差异可能仍然存在,从而阻止了应用块设计或t检验的标准格式。提供了理论上的考虑和工作实例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号